Results 1 to 10 of about 20,263 (262)

The Antiviral Activity of Varenicline against Dengue Virus Replication during the Post-Entry Stage [PDF]

open access: goldBiomedicines, 2023
Dengue virus (DENV) poses a significant global health challenge, with millions of cases each year. Developing effective antiviral drugs against DENV remains a major hurdle. Varenicline is a medication used to aid smoking cessation, with anti-inflammatory
Ching-Lin Lin   +10 more
doaj   +3 more sources

Visual hallucinations associated with varenicline: a case report [PDF]

open access: goldJournal of Medical Case Reports, 2009
Introduction Varenicline is widely used for smoking cessation. It has shown efficacy over placebo and bupropion in manufacturer-sponsored trials. Those with mental illness were excluded from these trials.
Raidoo B Mahendri, Kutscher Eric C
doaj   +2 more sources

Characteristics of first-time varenicline users – A cross-sectional study in Finnish quitters [PDF]

open access: goldBMC Public Health, 2017
Background Varenicline is an efficacious medicine for smoking cessation (SC) but little is known about the characteristics of varenicline users. This study examined the characteristics of first-time (naïve) varenicline users in Finland and compared those
Hanna E. Tervonen   +4 more
doaj   +2 more sources

Effect of varenicline on major adverse liver outcomes in alcohol-associated liver disease: An exploratory analysis. [PDF]

open access: yesAlcohol Clin Exp Res (Hoboken)
This real‐world study assessed whether varenicline improves outcomes in patients with ALD and AUD. Using data from a large electronic health record network, 1278 matched patients were analyzed. Varenicline use was associated with reduced all‐cause mortality and hepatic encephalopathy compared with FDA‐approved AUD therapies (acamprosate or naltrexone),
Danpanichkul P   +10 more
europepmc   +2 more sources

Hesperidin blocks varenicline-aggravated atherosclerotic plaque formation in apolipoprotein E knockout mice by downregulating net uptake of oxidized low-density lipoprotein in macrophages

open access: goldJournal of Pharmacological Sciences, 2020
Varenicline is a widely used and effective drug for smoking cessation. We have previously reported experimental evidence suggesting that varenicline increases the risk of cardiovascular events.
Mitsuhisa Koga   +5 more
doaj   +2 more sources

Effects of varenicline on sympatho-vagal balance and cue reactivity during smoking withdrawal: a randomised placebo-controlled trial [PDF]

open access: yesTobacco Induced Diseases, 2016
Introduction Varenicline is an effective smoking cessation medication. Some concern has been raised that its use may precipitate adverse cardiovascular events although no patho-physiological mechanism potentially underlying such an effect has been ...
Helge Haarmann   +7 more
doaj   +3 more sources

Efficacy of combined varenicline and nicotine replacement therapy compared with varenicline or nicotine replacement therapy alone for smoking cessation: A systematic review and meta‐analysis [PDF]

open access: hybridAddiction, EarlyView.
Abstract Aims To assess whether combining nicotine replacement therapy (NRT) with varenicline improves long‐term smoking cessation rates compared with varenicline or NRT alone. Method Systematic review and meta‐analysis of randomized controlled trials (RCTs) or quasi‐RCTs, conducted according to PRISMA guidelines.
Xinmei Zhou   +18 more
openalex   +2 more sources

Utilization of varenicline among Kansas Medicaid enrollees. [PDF]

open access: yesPLoS ONE
BackgroundSmoking prevalence among Medicaid beneficiaries is twice that of privately insured adults, yet effective smoking cessation treatments remain underutilized.
Nathalia M Machado   +3 more
doaj   +2 more sources

Reconsidering Ondansetron for Smoking Cessation: A Call for Renewed Investigation. [PDF]

open access: yesPharmacol Res Perspect
Pharmacology Research &Perspectives, Volume 13, Issue 6, December 2025.
Tam A, Munsar Z, Opler DJ.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy